Legal Representation
Attorney
Peter J. Willsey
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 22, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 22, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 17, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 13, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 13, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 13, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 14, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Nov 19, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 17, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 17, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 17, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 22, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 18, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 18, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 18, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 21, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 26, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 26, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 6, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 20, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 16, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 24, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; pharmaceutical preparations for the treatment and prevention of rhinitis; pharmaceutical preparations for the treatment and prevention of behcet disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of metastasis; pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions
Classification
International Classes
005